Understanding Treatment-Resistant Depression5 min read

What is treatment-resistant depression?

Treatment-resistant depression (TRD) is a term used when someone with major depressive disorder has not responded adequately to at least two different antidepressant trials at the right dose and duration. It is more common than most people realize — roughly one in three adults with depression fits this description.

Why medications sometimes fall short

Depression is not one illness with one cause. Genetics, inflammation, sleep, trauma history, and coexisting conditions like anxiety or ADHD all shape how someone responds to treatment. When the first medications don't work, it is a signal to look more carefully — not a sign that recovery is impossible.

Evidence-based next steps

• Medication optimization: adjusting dose, switching classes, or adding an augmenting agent.
• Transcranial Magnetic Stimulation (TMS): an FDA-cleared, non-invasive brain stimulation therapy performed in the office with no anesthesia and no systemic side effects.
• Spravato (esketamine): an FDA-approved nasal spray for TRD, given under medical supervision in a certified REMS clinic.
• Therapy pairing: CBT or interpersonal therapy alongside biological treatments typically outperforms either alone.

When to ask about advanced treatment

If you have tried two antidepressants without meaningful relief, or if side effects have limited your options, it is reasonable to ask your psychiatrist about TMS or Spravato. Earlier referral is associated with better long-term outcomes.

> Depression that hasn't responded to pills is still very treatable. The goal is remission — feeling like yourself again — not just fewer symptoms.